Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients
Introduction: Antiresorptive drugs are commonly used to treat cancer and bone metastases. These drugs can impose the risk of osteonecrosis of the jaw (ONJ). ONJ is a serious complication that can lead to significant morbidity and mortality. This study aimed to investigate the incidence and preventiv...
Saved in:
| Main Authors: | Salman Ali Alabdali, Abdulrahman Ali Alabdali, Sultan Qais Alnoaman, Abdullah Abuasida, Saud Balelah, Abdulaziz Almuzaini, Abdullah Homeed Almatrafi, Hossein M. Elbadawy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-12-01
|
| Series: | Saudi Dental Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1013905224003225 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01) -
Effects of discontinuing different antiresorptive regimens on medication-related osteonecrosis of the jaw in patients undergoing dental procedures: a systematic review and network meta-analysis
by: Kasidid Ruksakiet, et al.
Published: (2025-05-01) -
Dental care for patients taking antiresorptive drugs: a literature review
by: Minju Song
Published: (2019-11-01) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01) -
Time to initiation of antiresorptive agents in multiple myeloma to reduce skeletal related events
by: Amman Bhasin, et al.
Published: (2025-02-01)